after taking into account proceeds from the IPO, compared to $352.4 million as of December 31, 2024. Based on current operating plans, Metsera estimates its existing cash and cash equivalents will ...

Additionally, Metsera is accelerating its oral formulation program for MET-097o, with outcomes anticipated in late 2025. The recent $316 million IPO will support operations through 2027 as the ...

after taking into account proceeds from the IPO, compared to $352.4 million as of December 31, 2024. Based on current operating plans, Metsera estimates its existing cash and cash equivalents will ...

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq ... we successfully completed a $316 million IPO and continued to build on our track record of efficient and disciplined capital ...

Cash Position: Cash and cash equivalents were $588.3 million as of March 31, 2025, after taking into account proceeds from the IPO, compared to $352.4 million as of December 31, 2024. Based on current ...

Omada granted the offering's underwriters a 30-day option to purchase an undisclosed amount of additional shares of common stock at the IPO price. The offering lists Morgan Stanley, Goldman Sachs ...

PETALING JAYA: The price of Eco-Shop Marketing Bhd's shares for its initial public offering (IPO) has been fixed at RM1.13 a piece. In a filing with Bursa Malaysia, the retailing concern noted the ...

Others are also reviving their initial public offering (IPO) plans. US-based drug discovery firm Insilico Medicine submitted its application on Thursday, after its previous two attempts lapsed.

Omada is the second digital health company to announce plans IPO plans this year. In March, virtual musculoskeletal health company Hinge Health announced its plans for an IPO. Omada reported an ...

Data center operator CoreWeave is reportedly seeking a $1.5 billion debt deal after a disappointing IPO. According to the Financial Times, CoreWeave is holding a roadshow this week with bankers at ...